Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
ConditionVasculitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorUniversity Hospital, Tours
About this trial
To date, there are no reliable diagnostic blood markers of adult vasculitis. To date, the diagnosis of vasculitis is based on invasive procedure, biopsy of affected tissues potentially at risk of complication . In addition, there are no reliable biomarkers to predict the evolution of vasculitis (relapse, refractory form ...) necessary for the management of patients (type of treatment, duration ..)
Prospective study, monocentric (CHU de Tours), non-interventional, aimed at finding diagnostic and prognostic biomarkers (both metabolomic and immunologic) in adult vasculitis patients.
Eligibility criteria
Qualifiers
Age > 16 years
Active vasculitis, new diagnosis or relapse
IgA vasculitis
ANCA vasculitis
Disqualifiers
Person who has objected to the processing of data
Pregnant woman
Patient positive for HIV, HBV, HCV
Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.
Trial design
Treatments tested in this trial
- Sampling
Treatment groups
225 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov